TL;DR
- Semler Scientific plans to expand its Bitcoin holdings to 105,000 BTC by the end of 2027, after launching its strategy in May 2024.
- The company appointed Joe Burnett as Director of Bitcoin Strategy, adding operational and market expertise to drive its accumulation plan.
- Since adopting the Bitcoin Standard, the firm has achieved a 287% return and aims to scale before more companies follow that model.
Semler Scientific has decided to deepen its Bitcoin accumulation strategy and announced a plan to increase its holdings to 105,000 BTC by the end of 2027.
The company currently holds 4,449 BTC, valued at around $462 million, placing it among the fifteen largest corporate Bitcoin holders worldwide. This move builds on a policy launched in May 2024, when the firm formally adopted BTC as its primary treasury reserve asset.
To carry out this plan, it will use proceeds from equity offerings, debt placements, and cash flows from its medical technology business. According to its roadmap, the company expects to hold 10,000 BTC by the end of 2025 and reach 42,000 BTC by the close of 2026. The final goal of 105,000 BTC would position Semler as one of the largest institutional holders in the market.
Semler Scientific Hires Joe Burnett
As part of this strategy, the company appointed Joe Burnett as its Director of Bitcoin Strategy. Burnett is a well-respected figure in the sector, with experience at Unchained and Blockware Solutions. He has also worked as an analyst and commentator specializing in Bitcoin and financial markets, providing operational and market insight that aligns with the aggressive treasury policy the company is pursuing.
Since adopting its Bitcoin strategy, Semler Scientific has generated a 287% return on its BTC holdings, with $177 million in unrealized gains as of early June. These results supported the decision to scale up the strategy and secure a stronger position before more companies adopt similar policies.
Institutional Bitcoin Frenzy
Semler was the second publicly traded U.S. company to formally implement a Bitcoin treasury strategy, following MicroStrategy. Currently, around 230 firms have incorporated BTC into their reserves to varying degrees, though few have set such ambitious targets.
Alongside its crypto market activity, Semler continues to operate its medical technology business, with its flagship product QuantaFlo® — an FDA-cleared rapid test to measure arterial blood flow and detect cardiovascular risks. This combination of its core business with Bitcoin accumulation allows the company to diversify its financial profile without abandoning its primary operations.
